SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

An alleged leak of Phase 3 results for Modernas personalized melanoma vaccine with Merck has sparked a sharp selloff, with traders debating whether the reported benefit fell short of elevated expectations or whether the move reflects rumor-driven trading and manipulation. The datas significance remains disputed as investors await the full ESMO presentation.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A broad semiconductor and Nasdaq selloff has driven SOXL to a six-month low, with traders pointing to geopolitical tensions and higher oil, renewed concerns about AI financing, and weakness across chip stocks. The funds 3 daily leverage is intensifying the drop; the community is divided between buying the dip and warning that semiconductor weakness and leverage-related decay could bring further losses.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia shares sold off despite a quarterly earnings beat as traders focused on weaker free-cash-flow conversion guidance, negative cash flow, higher restructuring costs, and rising supply expenses. Bulls see the reaction as an overreaction and point to strong AI and cloud demand, while bears argue that cash generation and the cautious outlook matter more than the headline results.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A sharp reversal after SpaceXs earnings pop is being attributed by traders mainly to a large insider share unlock, with concerns about added selling pressure compounded by valuation and capital-spending worries and a broader tech-market selloff. Bulls are treating the decline as a buying opportunity, while bears argue the earnings beat does not justify the valuation; Tesla-merger speculation is also part of the debate.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

A sharp selloff in SanDisk and other memory stocks is driving discussion, with traders citing concerns about Chinese competition, uncertainty around AI spending and broader semiconductor weakness; some also describe the decline as unexplained or blame market manipulation. Bulls are buying the dip ahead of earnings and point to AI-driven NAND demand, while bears warn that memory-sector pressure could persist.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

CFO Ryan Fiedlers departure has triggered a sharp selloff and debate over whether the move signals undisclosed financial problems or is an overreaction; some traders cite the qualified internal successor and strong backlog as reasons for confidence, while others want more clarity from management.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under pressure as a broad tech and semiconductor selloff coincides with surging oil and Iran-related tensions, while renewed concerns about AI spending and fundingincluding comments on neocloud capital needsadd to risk-off sentiment. Traders are largely bearish and watching support, though some see the decline as a buying opportunity and expect a bounce.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

A sharp selloff in Intel shares, alongside weakness across semiconductor and AI stocks, dominates the discussion as traders weigh broad market pressure and uncertainty ahead of earnings. The community is split between calling the decline an oversold buying opportunity and warning that the sector downturn or Intels own risks could mean further downside; claims of deliberate shorting remain speculation.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas earnings beat and upbeat guidance were overshadowed by concerns about heavy AI infrastructure spending, negative free cash flow, and potential share dilution or outside financing. Traders are split between viewing the selloff as an overreaction and worrying that AI investment costs may outpace returns.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons rebound is being linked to Morgan Stanley naming it a top pick, alongside optimism about AWS growth and AI-related opportunities. Traders are cheering the upgrade but debating whether the gains can hold into the October 29 earnings report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced presentations related to its clinical development programs at the European Society for Medical Oncology (ESMO) Congress 2026, taking...

Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?

Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.

Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?

Teleflex (TFX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?

Veracyte (VCYT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Are Medical Stocks Lagging  Delcath Systems (DCTH) This Year?

Here is how Delcath Systems, Inc. (DCTH) and Encompass Health (EHC) have performed compared to their sector so far this year.

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Delcath Systems, Inc. (Nasdaq: DCTH) (the Company or Delcath), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Companys Compensation Committee, as material...

Zacks.com featured highlights include EuroDry, RCM, Assembly Biosciences, Delcath and National Energy Services

EuroDry, RCM Technologies, Assembly Biosciences, Delcath Systems and National Energy Services show strong price momentum after August's market gains.

Keep Portfolio Volatility in Check With VLO, PBF, FET & DCTH

VLO, PBF, FET and DCTH screen as low-beta picks as volatility rises, backed by refining, energy-equipment and liver-cancer growth drivers.

5 Stocks With Recent Price Strength Buoyed by a Strong August

EDRY, RCMT, ASMB, DCTH and NESR show strong recent price momentum after a strong August, backed by improving earnings expectations.


Delcath Systems to Participate in Upcoming Investor Conferences

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following investor conferences:Wells Fargo Healthcare Conference on Thursday, September 10, 2026...

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

These Two Stocks Hit Fresh 52-Week Highs Today – DCTH Clocks Best Day In Nearly 15 Months

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Delcath Systems raised its 2026 revenue guidance to $104 million to $108 million, up from its previous outlook of at least $100 million.</li><li>As of June 30, 2026, Delcath Systems had $95.9 million in cash and investments and no debt.</li><li>Praxis posted a loss of $2.87 per share, better than Wall Street’s estimates of a loss of $3.66 per share, according to Fiscal.ai.</li></ul>Shares of Delcath Systems (DCTH) and Praxis Precision Medicines (PRAX) hit fresh 52-week highs on Thursday, with DCTH recording its biggest single-day gains in nearly 15 months, after the companies posted better-than-expected second-quarter results.At the time of writing, <a href="https://stocktwits.com/symbol/DCTH">DCTH shares</a> traded 20% higher, having hit an intraday high of $15.62, while <a href="https://stocktwits.com/symbol/PRAX">PRAX stock</a> was up nearly 15%, after hitting an intraday high of $382.54.<h2 class="st-heading-2">DCTH Posts Profit After Two Quarters</h2>Delcath Systems reported better-than-expected second-quarter results, including a return to profitability after posting losses in the past two quarters. Revenue rose to $29.1 million from $24.2 million a year earlier, topping Wall Street estimates of $26.3 million, according to Fiscal.ai.The company posted earnings of $0.07 per share, compared with consensus estimates of a loss of $0.09 per share.Delcath Systems raised its 2026 revenue guidance to $104 million to $108 million, up from its previous outlook of at least $100 million. The company also expects full-year gross margins of 86% to 89%.As of June 30, 2026, Delcath Systems had $95.9 million in cash and investments and no debt.Retail sentiment surrounding DCTH on Stocktwits turned ‘bullish’ from ‘neutral’ over the past 24 hours, amid a 1,250% increase in message volumes. DCTH shares are up more than 53% so far this year.<h2 class="st-heading-2">PRAX’s Funds To Support Operations Till 2028</h2>Praxis Precision Medicines, a pre-revenue biotechnology firm, reported a second-quarter loss that was narrower than Wall Street expected, while ending the quarter with a cash position to support its pipeline through 2028.The company posted a net loss of $83.7 million, or $2.87 per share, better than Wall Street’s estimates of a loss of $3.66 per share, according to Fiscal.ai.Research and development expenses increased to $69.4 million from $63.0 million, primarily due to higher spending on its Solidus program, which is being developed to target rare and prevalent central nervous system (CNS) disorders, and increased personnel costs.As of June 30, 2026, Praxis held $1.4 billion in cash, cash equivalents, and marketable securities, up from $926.1 million at the end of 2025.Retail sentiment surrounding PRAX on Stocktwits flipped to ‘bullish’ from ‘bearish’ over the past 24 hours, amid ‘high’ message volumes. The stock is up more than 28% so far in 2026.Also read: <a href="https://stocktwits.com/news-articles/markets/equity/ast-space-mobile-taps-vodafone-deutsche-telekom-orange-for-europe-expansion-asts-stock-heads-for-best-week-in-over-a-month/cZoB5cfRJJO">AST SpaceMobile Taps Vodafone, Deutsche Telekom, Orange For Europe Expansion – ASTS Stock Heads For Best Week In Over A Month</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

(Photo credit should read INDRANIL MUKHERJEE/AFP via Getty Images)

Delcath Systems announced a return to profitability after posting losses in the past two quarters, while Praxis’ second-quarter loss came in narrower than Wall Street had expected

Praxis Precision Medicines Inc

Very bullish

Cautiously bullish

Cautiously bearish

Very bearish

Stocktwits sentiment on $SPY just hit its lowest level of the year. How are you feeling about the market right now?

Stocktwits

 just hit its lowest level of the year. How are you feeling about the market right now?

Current Price	$14.63
Prev Close	$14.70
Open	$14.68
Dividend Yield	0.00%
50-Day Moving Average	$16.00
Beta	1.30
Avg. Volume	352,593.53
PE Ratio	2,409.84

52-Week High	$17.42
52-Week Low	$8.12
Market Capitalization	$510.07M
EPS (Annual)	$0.0676
Price to Book	4.20
Revenue Per Employee	$546,352.56

Feed

News

Sentiment

Earnings

Fundamentals

Info

DCTH Fundamentals